DZ2979A1 - Composés nouveaux modulateurs de chimiokine ccr5, et compositions pharmaceutiques les contenant. - Google Patents

Composés nouveaux modulateurs de chimiokine ccr5, et compositions pharmaceutiques les contenant.

Info

Publication number: DZ2979A1
Authority: DZ; Algeria
Prior art keywords: ccr5; pharmaceutical compositions; compositions containing; modulator compounds; novel chemokine
Prior art date: 1998-12-23

Application number

DZ990279A

Other languages

English (en)

Inventor

Duncan Robert Armour

Blanda Luzia Christa Stammen

Manoussos Perros

David Anthony Price

Anthony Wood

Martin Paul Edwards

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-23

Filing date

1999-12-22

Publication date

2005-01-30

1998-12-23 Priority claimed from GBGB9828420.1A external-priority patent/GB9828420D0/en

1999-09-10 Priority claimed from GBGB9921375.3A external-priority patent/GB9921375D0/en

1999-12-22 Application filed by Pfizer filed Critical Pfizer

2001-11-19 Priority to DZ010081A priority Critical patent/DZ3326A1/fr

2005-01-30 Application granted granted Critical

2005-01-30 Publication of DZ2979A1 publication Critical patent/DZ2979A1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/18—Bridged systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/08—Bridged systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Epidemiology (AREA)
AIDS & HIV (AREA)
Rheumatology (AREA)
Endocrinology (AREA)
Tropical Medicine & Parasitology (AREA)
Molecular Biology (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Investigating Or Analysing Biological Materials (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

DZ990279A 1998-12-23 1999-12-22 Composés nouveaux modulateurs de chimiokine ccr5, et compositions pharmaceutiques les contenant. DZ2979A1 (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
DZ010081A DZ3326A1 (fr)	1998-12-23	2001-11-19	Composés nouveaux modulateurs de chimiokine ccr5, et compositions pharmaceutiques les contenant.

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9828420.1A GB9828420D0 (en)	1998-12-23	1998-12-23	CCR5 antagonists useful as anti-hiv agents
GBGB9921375.3A GB9921375D0 (en)	1999-09-10	1999-09-10	CCR5 Modulators

Publications (1)

Publication Number	Publication Date
DZ2979A1 true DZ2979A1 (fr)	2005-01-30

Family

ID=26314899

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DZ990279A DZ2979A1 (fr)	1998-12-23	1999-12-22	Composés nouveaux modulateurs de chimiokine ccr5, et compositions pharmaceutiques les contenant.
DZ010081A DZ3326A1 (fr)	1998-12-23	2001-11-19	Composés nouveaux modulateurs de chimiokine ccr5, et compositions pharmaceutiques les contenant.

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DZ010081A DZ3326A1 (fr)	1998-12-23	2001-11-19	Composés nouveaux modulateurs de chimiokine ccr5, et compositions pharmaceutiques les contenant.

Country Status (48)

Country	Link
US (1)	US6586430B1 (fr)
EP (1)	EP1140085B1 (fr)
JP (1)	JP3602795B2 (fr)
KR (1)	KR100425612B1 (fr)
CN (1)	CN1331591A (fr)
AP (1)	AP1697A (fr)
AR (1)	AR024233A1 (fr)
AT (1)	ATE505190T1 (fr)
AU (1)	AU763644B2 (fr)
BG (1)	BG65448B1 (fr)
BR (1)	BRPI9917007B8 (fr)
CA (1)	CA2350073C (fr)
CO (1)	CO5300387A1 (fr)
CR (2)	CR9879A (fr)
CU (1)	CU23344A3 (fr)
CY (1)	CY1111504T1 (fr)
CZ (1)	CZ300926B6 (fr)
DE (1)	DE69943352D1 (fr)
DK (1)	DK1140085T3 (fr)
DZ (2)	DZ2979A1 (fr)
EA (1)	EA004988B1 (fr)
EE (1)	EE05170B1 (fr)
EG (1)	EG24400A (fr)
GC (1)	GC0000117A (fr)
GE (1)	GEP20033131B (fr)
HK (1)	HK1039902A1 (fr)
HR (2)	HRP20010468B1 (fr)
HU (1)	HU228754B1 (fr)
ID (1)	ID28965A (fr)
IL (2)	IL143512A0 (fr)
IS (1)	IS5944A (fr)
MA (1)	MA26714A1 (fr)
ME (1)	ME00513B (fr)
NO (1)	NO330677B1 (fr)
NZ (1)	NZ511794A (fr)
OA (1)	OA11735A (fr)
PA (1)	PA8487201A1 (fr)
PE (1)	PE20001420A1 (fr)
PL (1)	PL201875B1 (fr)
PT (1)	PT1140085E (fr)
RS (1)	RS51701B (fr)
SI (1)	SI1140085T1 (fr)
SK (1)	SK287020B6 (fr)
TN (1)	TNSN99252A1 (fr)
TR (1)	TR200101793T2 (fr)
TW (1)	TW577888B (fr)
UA (1)	UA72750C2 (fr)
WO (1)	WO2000038680A1 (fr)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1013276A1 (fr) *	1998-12-23	2000-06-28	Pfizer Inc.	Aminoazacycloalcanes comme modulateurs de CCR5
US7217714B1 (en) *	1998-12-23	2007-05-15	Agouron Pharmaceuticals, Inc.	CCR5 modulators
US6399619B1 (en)	1999-04-06	2002-06-04	Merck & Co., Inc.	Pyrrolidine modulators of chemokine receptor activity
US6248755B1 (en)	1999-04-06	2001-06-19	Merck & Co., Inc.	Pyrrolidine modulators of chemokine receptor activity
SE9903544D0 (sv)	1999-10-01	1999-10-01	Astra Pharma Prod	Novel compounds
EP1118858A3 (fr) *	2000-01-12	2003-07-09	Pfizer Limited	Méthode d'essai
GB2359081A (en)	2000-02-11	2001-08-15	Astrazeneca Uk Ltd	Pharmaceutically active thiazolopyrimidines
GB2359078A (en)	2000-02-11	2001-08-15	Astrazeneca Uk Ltd	Pharmaceutically active pyrimidine derivatives
GB2359551A (en)	2000-02-23	2001-08-29	Astrazeneca Uk Ltd	Pharmaceutically active pyrimidine derivatives
GB0005642D0 (en) *	2000-03-10	2000-05-03	Astrazeneca Uk Ltd	Chemical compounds
SK286129B6 (sk)	2000-05-26	2008-04-07	Pfizer Inc.	Tropánové deriváty, ich použitie, spôsob a medziprodukt na ich výrobu, kombinácia a farmaceutická kompozícia s ich obsahom
US6667314B2 (en) *	2000-05-26	2003-12-23	Pfizer, Inc.	Tropane derivatives useful in therapy
GB0015562D0 (en) *	2000-06-23	2000-08-16	Pfizer Ltd	Heterocycles
US6531484B2 (en)	2000-10-11	2003-03-11	Merck & Co., Inc.	Pyrrolidine modulators of CCR5 chemokine receptor activity
US6511994B2 (en)	2000-10-11	2003-01-28	Merck & Co., Inc.	Modulators of CCR5 chemokine receptor activity
SE0003828D0 (sv)	2000-10-20	2000-10-20	Astrazeneca Ab	Novel compounds
EP1354587A1 (fr) *	2000-12-22	2003-10-22	Takeda Chemical Industries, Ltd.	Compositions medicinales s'administrant par voie orale
SE0101322D0 (sv)	2001-04-12	2001-04-12	Astrazeneca Ab	Novel compounds
SE0103818D0 (sv) *	2001-11-15	2001-11-15	Astrazeneca Ab	Chemical compounds
TW200305395A (en) *	2002-03-15	2003-11-01	Novartis Ag	Organic compounds
CN1324025C (zh) *	2002-04-08	2007-07-04	美国辉瑞有限公司	作为ccr5调节剂的托烷衍生物
US6855724B2 (en)	2002-04-08	2005-02-15	Agouron Pharmaceuticals, Inc.	Tropane derivatives useful in therapy
CA2485825A1 (fr) *	2002-05-23	2003-12-04	Pfizer Inc.	Procede d'identification d'un ligand faisant appel a la mesure du temps de sejour sur le recepteur
GB0221828D0 (en)	2002-09-20	2002-10-30	Astrazeneca Ab	Novel compound
US7202259B2 (en)	2002-11-18	2007-04-10	Euro-Celtique S.A.	Therapeutic agents useful for treating pain
JP4666256B2 (ja) *	2002-12-10	2011-04-06	小野薬品工業株式会社	含窒素複素環化合物およびその医薬用途
RU2005118407A (ru) *	2002-12-13	2006-03-10	СмитКлайн Бичем Корпорейшн (US)	Производные пиперидина в качестве антагонистов ccr5
JP2006514950A (ja)	2002-12-13	2006-05-18	スミスクラインビーチャムコーポレーション	Ｃｃｒ５拮抗薬としてのシクロプロピル化合物
NZ542304A (en)	2003-03-14	2009-07-31	Ono Pharmaceutical Co	Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
JP4710606B2 (ja)	2003-04-18	2011-06-29	小野薬品工業株式会社	スピロピペリジン化合物およびその医薬用途
ES2285485T3 (es) *	2003-07-31	2007-11-16	Astrazeneca Ab	Derivados de piperidina como moduladores del receptor ccr5.
US7220772B2 (en)	2003-09-05	2007-05-22	Pfizer, Inc.	Pyrazole derivatives
WO2005023810A1 (fr)	2003-09-10	2005-03-17	Virochem Pharma Inc.	Composes de spirohydantoine et procedes de modulation de l'activite des recepteurs de chimiokine
DE602004010708T2 (de) *	2003-10-03	2008-12-04	Pfizer Inc.	Imidazopyridinsubstituierte tropanderivate mit ccr5-rezeptorantagonistischer wirkung zur behandlung von hiv und entzündungen
GB0328243D0 (en)	2003-12-05	2004-01-07	Astrazeneca Ab	Methods
BRPI0506548A (pt) *	2004-01-30	2007-05-02	Euro Celtique Sa	métodos para produzir compostos de 4-tetrazolil-4-fenilpiperidina
TW200533348A (en)	2004-02-18	2005-10-16	Theravance Inc	Indazole-carboxamide compounds as 5-ht4 receptor agonists
MXPA06011884A (es) *	2004-04-14	2006-12-14	Pfizer	Compuestos de imidazol unidos a azufre para el tratamiento del virus de inmunodeficiencia humana.
TW200610761A (en) *	2004-04-23	2006-04-01	Astrazeneca Ab	Chemical compounds
ES2297727T3 (es)	2004-06-09	2008-05-01	F. Hoffmann-La Roche Ag	Derivados de octahidropirrolo(3,4-c)pirrol y su empleo como agentes antiviricos.
PE20090123A1 (es)	2004-09-13	2009-03-10	Ono Pharmaceutical Co	Un derivado heterociclico conteniendo nitrogeno y un farmaco conteniendo el mismo como el ingrediente activo
JP2008534654A (ja) *	2005-04-08	2008-08-28	ノイロサーチアクティーゼルスカブ	（＋）−及び（−）−８−アルキル−３−（トリフルオロアルキルスルホニルオキシ）−８−アザビシクロ（３．２．１）オクト−２−エン
AU2006233537A1 (en)	2005-04-14	2006-10-19	F. Hoffmann-La Roche Ag	Aminopyrazole derivatives, their manufacture and use as pharmaceutical agents
US20110052612A1 (en)	2005-05-31	2011-03-03	Ono Pharmaceutical Co., Ltd.	Spiropiperidine compound and medicinal use thereof
US7665658B2 (en)	2005-06-07	2010-02-23	First Data Corporation	Dynamic aggregation of payment transactions
ES2277745B1 (es) *	2005-06-14	2008-06-01	Laboratorios Almirall S.A.	Derivados n-amida de 8-azabiciclo /3.2.1/oct-3-ilo como antagonistas de ccr1.
JP5251127B2 (ja)	2005-10-28	2013-07-31	小野薬品工業株式会社	塩基性基を含有する化合物およびその用途
ES2407115T3 (es)	2005-11-18	2013-06-11	Ono Pharmaceutical Co., Ltd.	Compuesto que contiene un grupo básico y uso del mismo
AU2007225836A1 (en)	2006-03-10	2007-09-20	Ono Pharmaceutical Co., Ltd.	Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
US20080015833A1 (en) *	2006-07-13	2008-01-17	Searete Llc, A Limited Liability Corporation Of The State Of Delaware	Methods and systems for molecular inhibition of protein misfolding
US20080015835A1 (en) *	2006-07-13	2008-01-17	Searete Llc, A Limited Liability Corporation Of The State Of Delaware	Methods and systems for treating disease
US20090082344A1 (en) *	2006-07-13	2009-03-26	Searete Llc	Methods and systems for treating disease
US20080014572A1 (en) *	2006-07-13	2008-01-17	Searete Llc, A Limited Liability Corporation Of The State Of Delaware	Methods and systems for molecular inhibition
EP2055705A4 (fr)	2006-07-31	2014-08-20	Ono Pharmaceutical Co	Composé auquel un groupe cyclique est lié par une liaison spiro et son utilisation
EP2121676A1 (fr) *	2006-12-19	2009-11-25	Auspex Pharmaceuticals, Inc.	Préparation et utilité d'inhibiteurs de ccr5
MX2010002449A (es)	2007-08-31	2010-09-07	Purdue Pharma Lp	Compuestos de piperidina tipo quinoxalina sustituida y uso de los mismsos.
WO2010129351A1 (fr)	2009-04-28	2010-11-11	Schepens Eye Research Institute	Procédé pour identifier et pour traiter une dégénérescence maculaire liée à l'âge
WO2011011652A1 (fr)	2009-07-24	2011-01-27	Glaxosmithkline Llc	Composés thérapeutiques
EP2552429A1 (fr)	2010-04-02	2013-02-06	Phivco-1 LLC	Traitement d'association comprenant un antagoniste du récepteur ccr5, un inhibiteur de la protéase du vih-1 et un accélérateur pharmacocinétique
JP2014518610A (ja)	2011-03-09	2014-08-07	リチャードジー．ペステル	前立腺癌細胞系、遺伝子シグネチャー及びその使用
US20140271680A1 (en)	2011-08-12	2014-09-18	Universite Paris-Est Creteil Val De Marne	Methods and pharmaceutical compositions for treatment of pulmonary hypertension
JP6518585B2 (ja) *	2012-05-14	2019-05-22	リチャードジー．ペステル	がんの治療のためのｃｃｒ５の修飾薬の使用
US9090618B2 (en)	2012-12-27	2015-07-28	Purdue Pharma L.P.	Substituted benzimidazole-type piperidine compounds and uses thereof
EP3826659B1 (fr) *	2018-07-10	2024-06-19	Rush University Medical Center	Immunomodulateur destiné à être utilisé dans le traitement d'une infection bactérienne
CN115443133B (zh)	2020-02-19	2024-02-20	伊契洛夫科技有限公司	改进的抗抑郁疗法
US11629196B2 (en)	2020-04-27	2023-04-18	Incelldx, Inc.	Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions
WO2021257420A1 (fr) *	2020-06-17	2021-12-23	Merck Sharp & Dohme Corp.	2-oxoimidazolidine-3-carboxamides utiles en tant qu'inhibiteurs de nav1.8

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9125900D0 (en)	1991-12-05	1992-02-05	Wyeth John & Brother Ltd	Piperazine derivatives
PH30413A (en)	1992-03-26	1997-05-09	Boehringer Ingelheim Italia	Crystalline forms of endo-2,3-dihydro-n-(8-methyl)-8-azabicyclo-(3,2,1)oct-3-yl)-2-oxo-1h-benzimidazole-1-carboxamides
GB9310713D0 (en) *	1993-05-24	1993-07-07	Zeneca Ltd	Aryl substituted heterocycles
FR2728166A1 (fr)	1994-12-19	1996-06-21	Oreal	Composition topique contenant un antagoniste de substance p
DE19500120A1 (de) *	1995-01-04	1996-07-11	Bayer Ag	Neue acylierte Pseudopeptide mit trifluormethyl-subsstituiertem 2-Azabicyclooctan
GB9502644D0 (en) *	1995-02-10	1995-03-29	Zeneca Ltd	Heterocyclic derivatives
GB9523526D0 (en) *	1995-11-17	1996-01-17	Zeneca Ltd	Therapeutic compounds
WO1997024325A1 (fr) *	1995-12-28	1997-07-10	Takeda Chemical Industries, Ltd.	DERIVES DE DIPHENYLMETHANE UTILISES COMME ANTAGONISTES DU RECEPTEUR MIP-1α/RANTES
KR100313641B1 (ko) *	1996-03-29	2002-02-19	디. 제이. 우드, 스피겔 알렌 제이	6-페닐피리딜-2-아민유도체
US6323206B1 (en) *	1996-07-12	2001-11-27	Millennium Pharmaceuticals, Inc.	Chemokine receptor antagonists and methods of use therefor
WO1998002151A2 (fr) *	1996-07-12	1998-01-22	Leukosite, Inc.	Antagonistes des recepteurs de la chemokine et procedes d'utilisation de ces derniers
CA2261633A1 (fr) *	1996-07-29	1998-02-05	Banyu Pharmaceutical Co., Ltd.	Antagonistes de recepteurs de chemokines
AU5604998A (en)	1996-12-13	1998-07-03	Merck & Co., Inc.	Spiro-substituted azacycles as modulators of chemokine receptor activity
AU5522498A (en)	1996-12-13	1998-07-03	Merck & Co., Inc.	Substituted aryl piperazines as modulators of chemokine receptor activity
WO1998025605A1 (fr)	1996-12-13	1998-06-18	Merck & Co., Inc.	Azacycles spiro-substitues utilises comme modulateurs de l'activite des recepteurs de la chemokine
EP1003743A4 (fr)	1997-01-21	2001-04-11	Merck & Co Inc	Piperidines 3,3-disubstituees utilisees comme modulateurs de l'activite de recepteurs de chemokines
WO1999004794A1 (fr)	1997-07-25	1999-02-04	Merck & Co., Inc.	Amines cycliques modulant l'activite des recepteurs de chimiokines
IL125658A0 (en) *	1997-08-18	1999-04-11	Hoffmann La Roche	Ccr-3 receptor antagonists
WO1999009984A1 (fr)	1997-08-28	1999-03-04	Merck & Co., Inc.	Modulateurs de pyrrolidine et de piperidine de l'activite du recepteur de chemokine
AR013669A1 (es) *	1997-10-07	2001-01-10	Smithkline Beecham Corp	Compuestos y metodos
JP2002501052A (ja) *	1998-01-21	2002-01-15	ミレニアム・ファーマシューティカルズ・インコーポレイテッド	ケモカイン受容体アンタゴニストおよびその使用方法

1999
- 1999-11-29 PE PE1999001190A patent/PE20001420A1/es not_active IP Right Cessation
- 1999-11-30 AR ARP990106086A patent/AR024233A1/es active IP Right Grant
- 1999-12-01 US US09/452,578 patent/US6586430B1/en not_active Expired - Lifetime
- 1999-12-02 TW TW088121100A patent/TW577888B/zh not_active IP Right Cessation
- 1999-12-02 CO CO99075874A patent/CO5300387A1/es not_active Application Discontinuation
- 1999-12-10 PA PA19998487201A patent/PA8487201A1/es unknown
- 1999-12-14 EG EG159299A patent/EG24400A/xx active
- 1999-12-21 GC GCP1999452 patent/GC0000117A/xx active
- 1999-12-22 MA MA25868A patent/MA26714A1/fr unknown
- 1999-12-22 TN TNTNSN99252A patent/TNSN99252A1/fr unknown
- 1999-12-22 DZ DZ990279A patent/DZ2979A1/fr active
- 1999-12-22 ID IDW00200101366A patent/ID28965A/id unknown
- 1999-12-23 OA OA1200100164A patent/OA11735A/en unknown
- 1999-12-23 JP JP2000590634A patent/JP3602795B2/ja not_active Expired - Lifetime
- 1999-12-23 EE EEP200100345A patent/EE05170B1/xx unknown
- 1999-12-23 NZ NZ511794A patent/NZ511794A/en not_active IP Right Cessation
- 1999-12-23 DK DK99959624.0T patent/DK1140085T3/da active
- 1999-12-23 WO PCT/IB1999/002048 patent/WO2000038680A1/fr active Application Filing
- 1999-12-23 EP EP99959624A patent/EP1140085B1/fr not_active Expired - Lifetime
- 1999-12-23 GE GEAP19995958A patent/GEP20033131B/en unknown
- 1999-12-23 SI SI9931056T patent/SI1140085T1/sl unknown
- 1999-12-23 SK SK875-2001A patent/SK287020B6/sk not_active IP Right Cessation
- 1999-12-23 CZ CZ20012298A patent/CZ300926B6/cs not_active IP Right Cessation
- 1999-12-23 PT PT99959624T patent/PT1140085E/pt unknown
- 1999-12-23 UA UA2001064397A patent/UA72750C2/uk unknown
- 1999-12-23 IL IL14351299A patent/IL143512A0/xx unknown
- 1999-12-23 TR TR2001/01793T patent/TR200101793T2/xx unknown
- 1999-12-23 KR KR10-2001-7008122A patent/KR100425612B1/ko active IP Right Grant
- 1999-12-23 AU AU16751/00A patent/AU763644B2/en not_active Expired
- 1999-12-23 CN CN99815033A patent/CN1331591A/zh active Pending
- 1999-12-23 EA EA200100589A patent/EA004988B1/ru not_active IP Right Cessation
- 1999-12-23 ME MEP-2008-837A patent/ME00513B/fr unknown
- 1999-12-23 BR BRPI9917007A patent/BRPI9917007B8/pt not_active IP Right Cessation
- 1999-12-23 AT AT99959624T patent/ATE505190T1/de active
- 1999-12-23 CA CA002350073A patent/CA2350073C/fr not_active Expired - Lifetime
- 1999-12-23 HU HU0104795A patent/HU228754B1/hu unknown
- 1999-12-23 AP APAP/P/2001/002186A patent/AP1697A/en active
- 1999-12-23 DE DE69943352T patent/DE69943352D1/de not_active Expired - Lifetime
- 1999-12-23 PL PL349495A patent/PL201875B1/pl unknown
- 1999-12-23 RS YU38801A patent/RS51701B/sr unknown
2001
- 2001-05-15 IS IS5944A patent/IS5944A/is unknown
- 2001-05-31 IL IL143512A patent/IL143512A/en not_active IP Right Cessation
- 2001-06-14 CR CR9879A patent/CR9879A/es unknown
- 2001-06-14 CR CR6392A patent/CR6392A/es unknown
- 2001-06-19 HR HRP20010468AA patent/HRP20010468B1/xx not_active IP Right Cessation
- 2001-06-22 CU CU20010145A patent/CU23344A3/es unknown
- 2001-06-25 NO NO20013183A patent/NO330677B1/no not_active IP Right Cessation
- 2001-07-20 BG BG105721A patent/BG65448B1/bg unknown
- 2001-11-19 DZ DZ010081A patent/DZ3326A1/fr active
2002
- 2002-02-27 HK HK02101507.2A patent/HK1039902A1/zh unknown
2011
- 2011-05-17 CY CY20111100484T patent/CY1111504T1/el unknown
2012
- 2012-02-09 HR HRP20120132AA patent/HRP20120132B1/hr not_active IP Right Cessation

Also Published As

Publication number	Publication date
UA72750C2 (en)	2005-04-15
BG65448B1 (bg)	2008-08-29
TNSN99252A1 (fr)	2005-11-10
CA2350073A1 (fr)	2000-07-06
ATE505190T1 (de)	2011-04-15
GC0000117A (en)	2005-06-29
CZ20012298A3 (cs)	2002-09-11
CO5300387A1 (es)	2003-07-31
HRP20120132A8 (hr)	2017-11-03
IL143512A (en)	2013-06-27
AP1697A (en)	2006-12-22
SI1140085T1 (sl)	2011-08-31
CA2350073C (fr)	2007-04-17
TW577888B (en)	2004-03-01
ID28965A (id)	2001-07-19
AU763644B2 (en)	2003-07-31
HRP20120132B1 (hr)	2018-01-26
ME00513B (fr)	2011-10-10
NO330677B1 (no)	2011-06-06
US6586430B1 (en)	2003-07-01
HRP20010468B1 (en)	2012-06-30
HUP0104795A3 (en)	2002-05-28
EE05170B1 (et)	2009-06-15
SK287020B6 (sk)	2009-09-07
YU38801A (sh)	2005-06-10
WO2000038680A1 (fr)	2000-07-06
OA11735A (en)	2005-05-12
CY1111504T1 (el)	2015-08-05
DK1140085T3 (da)	2011-06-27
IL143512A0 (en)	2002-04-21
JP3602795B2 (ja)	2004-12-15
HUP0104795A2 (hu)	2002-04-29
DZ3326A1 (fr)	2005-05-29
CN1331591A (zh)	2002-01-16
JP2002533393A (ja)	2002-10-08
NZ511794A (en)	2003-10-31
NO20013183L (no)	2001-08-08
AP2001002186A0 (en)	2001-06-30
BR9917007A (pt)	2001-10-30
HRP20010468A2 (en)	2003-02-28
BG105721A (en)	2002-02-28
HU228754B1 (en)	2013-05-28
PT1140085E (pt)	2011-06-16
CZ300926B6 (cs)	2009-09-09
CR6392A (es)	2006-08-09
EA200100589A1 (ru)	2002-02-28
PE20001420A1 (es)	2000-12-18
KR100425612B1 (ko)	2004-04-01
NO20013183D0 (no)	2001-06-25
BRPI9917007B1 (pt)	2016-07-26
AR024233A1 (es)	2002-09-25
EE200100345A (et)	2002-12-16
PL349495A1 (en)	2002-07-29
EA004988B1 (ru)	2004-10-28
CR9879A (es)	2008-06-20
PL201875B1 (pl)	2009-05-29
PA8487201A1 (es)	2002-02-21
DE69943352D1 (de)	2011-05-26
HK1039902A1 (zh)	2002-05-17
BRPI9917007B8 (pt)	2021-05-25
CU23344A3 (es)	2009-02-20
AU1675100A (en)	2000-07-31
GEP20033131B (en)	2003-12-25
SK8752001A3 (en)	2003-02-04
MA26714A1 (fr)	2004-12-20
TR200101793T2 (tr)	2001-12-21
IS5944A (is)	2001-05-15
KR20010089701A (ko)	2001-10-08
EP1140085B1 (fr)	2011-04-13
EG24400A (en)	2009-04-29
RS51701B (sr)	2011-10-31
EP1140085A1 (fr)	2001-10-10
HRP20120132A2 (hr)	2012-03-31

Publication	Publication Date	Title
DZ2979A1 (fr)	2005-01-30	Composés nouveaux modulateurs de chimiokine ccr5, et compositions pharmaceutiques les contenant.
DZ2978A1 (fr)	2004-07-04	Composés chimiques nouveaux modulateurs de ccr5, et compositions pharmaceutiques les contenant.
DZ2964A1 (fr)	2004-03-15	Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
DZ1916A1 (fr)	2002-02-17	Composés nouveaux et compostions pharmaceutiques les contenant.
DZ2086A1 (fr)	2002-07-22	Benzylaminopipéridines substituées et compositionspharmaceutiques les contenant.
DZ2887A1 (fr)	2003-12-15	Dérivés d'azétidine, leur préparation et les médicaments les contenant.
DZ2594A1 (fr)	2003-02-22	Dérivés de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant.
MA24529A1 (fr)	1998-12-31	Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions les contenant .
FR2715847B1 (fr)	1996-04-12	Composition contenant des acides nucléiques, préparation et utilisations.
MA26490A1 (fr)	2004-12-20	Derives de tetrahydroisoquinoleine nouveaux, procedes pour leur preparation et compositions pharmaceutiques les contenant.
MA26551A1 (fr)	2004-12-20	Agonistes de prostaglandines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
DZ2494A1 (fr)	2003-01-25	Composition pharmaceutique d'oméprazole.
DZ2890A1 (fr)	2003-12-15	4-Carboxamino-2-substitué-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2461A1 (fr)	2003-01-18	Dérivés d'arylkylamines nouveaux et composition pharmaceutiques les contenant.
DZ2009A1 (fr)	2002-10-23	Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
DZ2745A1 (fr)	2003-09-08	BicycloÄ2.2.1Üheptanes nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ3191A1 (fr)	2001-01-11	Composés d'indazole et compositions pharmaceutiques inhibant les protéines kinases, et procédés d'utilisation de ceux-ci.
FR2732967B1 (fr)	1997-07-04	1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant
MA26472A1 (fr)	2004-12-20	Derives de n-hydroxy-b-sulfonylpropionamide, procede pour leur preparation et compositions pharmaceutiques les contenant.
DZ2149A1 (fr)	2002-10-23	Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
MA26630A1 (fr)	2004-12-20	4-phenylpyperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
DZ2479A1 (fr)	2003-02-01	Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant.
CH689805A8 (fr)	2000-02-29	Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
DZ2188A1 (fr)	2002-12-02	Dérivés de quinoxalinedone, procédés et intermédiaires pour leur préparation et compositions pharmaceutiques les contenant.
MA26707A1 (fr)	2004-12-20	Azalides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.